Rheumatology Skip Menu Navigate: Select to Navigate... - Rheumatology Home - Our Team -- Faculty -- APPs -- Staff - Patient Care -- Clinical Services -- Clinic Locations -- Meet Our Clinicians -- Resources -- UTMB Health Rheumatology - Fellowship Program -- Overview -- Our Fellows -- Clinical Experiences -- Conferences -- How to Apply - Research -- Research Team -- Research Projects - Contact Us Rheumatology Home Our Team Faculty APPs Staff Patient Care Clinical Services Clinic Locations Meet Our Clinicians Resources UTMB Health Rheumatology Fellowship Program Overview Our Fellows Clinical Experiences Conferences How to Apply Research Research Team Research Projects Contact Us Research Projects Antiphospholipid Antibodies and Lupus: New Molecular Targets for Treatment, NIH-sponsored, 2013 - present A Multicenter International Prospective, Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of Persistently Antiphospholipid Antibody (aPL) Positive but Thombosis-free Patients without Systemic Autoimmune Disease, 2013 - present An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome, 2013 - present A Phase IIb, Multi-Center, Randomized, Double-Blind,Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept (TACI-Ig) in Subjects With Systemic Lupus Erythematosus (SLE), 2014 - present. "Treat-to-Target", a multi-center trial of RA, NIH-sponsored, out of Harvard university, Boston, under the leadership of Dr. Daniel Salomon, 2014 - present Determination of cultured endothelial cells to examine the effects of various inhibitors that may block their binding and activation determine their thrombogenic effects in mice, 2007 - present Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) International Clinical Database and Repository Collaborative Registry, 2013 - present